Pristiq

Product NDC: 0008-1211
11-digit product format: 000081211
Labeler code: 0008
Product ID: 0008-1211_b9acfefd-10c0-4942-9446-18bb456efb68
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: desvenlafaxine succinate
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Application: NDA021992
Marketing category: NDA
Marketing start: 2008-05-01
Substance: DESVENLAFAXINE SUCCINATE
Active strength: 50 mg/1
Pharmacologic classes: Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021992-001	PRISTIQ	DESVENLAFAXINE SUCCINATE	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29
N021992-002	PRISTIQ	DESVENLAFAXINE SUCCINATE	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29
N021992-003	PRISTIQ	DESVENLAFAXINE SUCCINATE	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N021992-001	AB
N021992-002	AB
N021992-003	AB

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N021992-001	8269040	2027-07-05	Drug substance
N021992-002	8269040	2027-07-05	Drug substance
N021992-003	8269040	2027-07-05	Drug substance	2015-02-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-002	PRISTIQ	EQ 100MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-02-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-003	PRISTIQ	EQ 25MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2014-08-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021992-001	PRISTIQ	EQ 50MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-02-29	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021992-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021992-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021992-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021992-001	AB	1	`8072bd15b7f6…`

Observed Orange Book patent history#

Patent history page 1 of 6 · 231 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021992-001	8269040	2027-07-05	Drug substance		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-002	8269040	2027-07-05	Drug substance		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-001	8269040	2027-07-05	Drug substance		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-002	8269040	2027-07-05	Drug substance		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021992-001	8269040	2027-07-05	Drug substance		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-002	8269040	2027-07-05	Drug substance		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-001	8269040	2027-07-05	Drug substance		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-002	8269040	2027-07-05	Drug substance		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-001	8269040	2027-07-05	Drug substance		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-002	8269040	2027-07-05	Drug substance		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-001	8269040	2027-07-05	Drug substance		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-002	8269040	2027-07-05	Drug substance		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-001	8269040	2027-07-05	Drug substance		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-002	8269040	2027-07-05	Drug substance		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-001	8269040	2027-07-05	Drug substance		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-002	8269040	2027-07-05	Drug substance		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-001	8269040	2027-07-05	Drug substance		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-002	8269040	2027-07-05	Drug substance		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021992-001	8269040	2027-07-05	Drug substance		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-002	8269040	2027-07-05	Drug substance		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-001	8269040	2027-07-05	Drug substance		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-002	8269040	2027-07-05	Drug substance		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-001	8269040	2027-07-05	Drug substance		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-002	8269040	2027-07-05	Drug substance		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-001	8269040	2027-07-05	Drug substance		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-002	8269040	2027-07-05	Drug substance		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021992-003	8269040	2027-07-05	Drug substance	2015-02-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021992-001	8269040	2027-07-05	Drug substance		`8072bd15b7f6…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021992-001	M-222	2021-02-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021992-002	M-222	2021-02-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021992-003	M-222	2021-02-06	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N021992-001	M-222	2021-02-06	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021992-002	M-222	2021-02-06	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021992-003	M-222	2021-02-06	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021992-001	M-222	2021-02-06	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021992-002	M-222	2021-02-06	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021992-003	M-222	2021-02-06	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021992-001	M-222	2021-02-06	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021992-002	M-222	2021-02-06	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021992-003	M-222	2021-02-06	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021992-001	M-222	2021-02-06	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021992-002	M-222	2021-02-06	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021992-003	M-222	2021-02-06	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021992-001	M-222	2021-02-06	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021992-002	M-222	2021-02-06	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021992-003	M-222	2021-02-06	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021992-001	M-222	2021-02-06	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021992-002	M-222	2021-02-06	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021992-003	M-222	2021-02-06	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021992-001	M-222	2021-02-06	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021992-002	M-222	2021-02-06	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021992-003	M-222	2021-02-06	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021992-001	M-222	2021-02-06	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021992-002	M-222	2021-02-06	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021992-003	M-222	2021-02-06	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Pristiq
Brand name suffix: Extended-Release
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DESVENLAFAXINE SUCCINATE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ZB22ENF0XR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
790267	Internal RxNorm lookup
790290	Internal RxNorm lookup
1607617	Internal RxNorm lookup
1607619	Internal RxNorm lookup
1874553	Internal RxNorm lookup
1874559	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0f43610c-f290-46ea-d186-4f998ed99fce	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a9aae381-3b13-08a9-c49d-484a2c2a6dc8	Product name	7	20251106
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
99b326f2-4886-9fc8-8686-faef7b7f27dd	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
0008-1211-01	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-01	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-01	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-01	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-14	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-14	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-14	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-14	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-30	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-30	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-30	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-30	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-50	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-50	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-50	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
0008-1211-50	These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0008-1211-01	PristiqExtended-Release	90 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	90	67
0008-1211-14	PristiqExtended-Release	14 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	14	67
0008-1211-30	PristiqExtended-Release	30 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	30	67
0008-1211-50	PristiqExtended-Release	100 in 1 CARTON	TABLET, EXTENDED RELEASE	100	67
0008-1211-50	PristiqExtended-Release	1 in 1 BLISTER PACK	TABLET, EXTENDED RELEASE	1	67

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0008-1211-01	EA - Each	0008-1211	d4213829-8cc2-4e1e-943c-3c2affb87d77	1	2012-07-24
0008-1211-14	EA - Each	0008-1211	2b330d69-6976-450b-adf7-399695ee02fa	1	2012-07-24
0008-1211-30	EA - Each	0008-1211	a4f1b618-aecf-4469-98c4-8eb2798c5526	1	2012-07-24
0008-1211-50	EA - Each	0008-1211	a4467bd9-5427-4027-aa6f-6438b7812711	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DESVENLAFAXINE SUCCINATE	ACTIVE INGREDIENT	ZB22ENF0XR	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
DESVENLAFAXINE	ACTIVE MOIETY	NG99554ANW	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
HYPROMELLOSE 2208 (15000 MPA.S)	INACTIVE INGREDIENT	Z78RG6M2N2	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]	47
DESVENLAFAXINE SUCCINATE	ACTIVE INGREDIENT	ZB22ENF0XR	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
DESVENLAFAXINE SUCCINATE	ACTIVE INGREDIENT	ZB22ENF0XR	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
DESVENLAFAXINE	ACTIVE MOIETY	NG99554ANW	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
DESVENLAFAXINE	ACTIVE MOIETY	NG99554ANW	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSE 2208 (15000 CPS)	INACTIVE INGREDIENT	Z78RG6M2N2	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
HYPROMELLOSE 2208 (15000 MPA.S)	INACTIVE INGREDIENT	Z78RG6M2N2	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0008-1211	PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.]	64	Current NDC, Legacy NDC, 5 package rows	20241219_0f43610c-f290-46ea-d186-4f998ed99fce.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pristiq Extended-Release	DESVENLAFAXINE SUCCINATE	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	0f43610c-f290-46ea-d186-4f998ed99fce	2026-04-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021992 application number: NDA021992 ndc (product): 0008-1211

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
ZB22ENF0XR	DESVENLAFAXINE SUCCINATE	386750-22-7	DESVENLAFAXINE SUCCINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1874553	desvenlafaxine succinate 100 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607617	desvenlafaxine succinate 25 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874559	desvenlafaxine succinate 50 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
790267	Pristiq 100 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607619	Pristiq 25 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
790290	Pristiq 50 MG 24HR Extended Release Oral Tablet	PSN	0f43610c-f290-46ea-d186-4f998ed99fce	67
790267	24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq]	SBD	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607619	24 HR desvenlafaxine succinate 25 MG Extended Release Oral Tablet [Pristiq]	SBD	0f43610c-f290-46ea-d186-4f998ed99fce	67
790290	24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet [Pristiq]	SBD	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874553	24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet	SCD	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607617	24 HR desvenlafaxine succinate 25 MG Extended Release Oral Tablet	SCD	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874559	24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet	SCD	0f43610c-f290-46ea-d186-4f998ed99fce	67
790267	24 HR Pristiq 100 MG Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607619	24 HR Pristiq 25 MG Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
790290	24 HR Pristiq 50 MG Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874553	desvenlafaxine 100 MG (as desvenlafaxine succinate 152 MG) 24HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607617	desvenlafaxine 25 MG (as desvenlafaxine succinate 38 MG) 24HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874559	desvenlafaxine 50 MG (as desvenlafaxine succinate 76 MG) 24HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
790267	Pristiq 100 MG (as desvenlafaxine succinate 152 MG) 24 HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1607619	Pristiq 25 MG (as desvenlafaxine succinate 38 MG) 24 HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
790290	Pristiq 50 MG (as desvenlafaxine succinate 76 MG) 24 HR Extended Release Oral Tablet	SY	0f43610c-f290-46ea-d186-4f998ed99fce	67
1874559	desvenlafaxine succinate 50 MG 24HR Extended Release Oral Tablet	PSN	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
790290	Pristiq 50 MG 24HR Extended Release Oral Tablet	PSN	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
790290	24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet [Pristiq]	SBD	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
1874559	24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet	SCD	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
790290	24 HR Pristiq 50 MG Extended Release Oral Tablet	SY	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
1874559	desvenlafaxine 50 MG (as desvenlafaxine succinate 76 MG) 24HR Extended Release Oral Tablet	SY	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1
790290	Pristiq 50 MG (as desvenlafaxine succinate 76 MG) 24 HR Extended Release Oral Tablet	SY	32d632f6-e7cc-455e-bd9a-3dcfc99a794f	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0008-1211-01	00008121101	90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-01)		2008-05-01	0000-00-00	No	No	Current
0008-1211-14	00008121114	14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-14)		2008-05-01	0000-00-00	No	No	Current
0008-1211-30	00008121130	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-30)		2008-05-01	0000-00-00	No	No	Current
0008-1211-50	00008121150	100 BLISTER PACK in 1 CARTON (0008-1211-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK	100 blister pack	2008-05-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pristiq Extended-Release	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. \| Pfizer Inc \| Pfizer Asia Manufacturing Pte Ltd \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Pharmacia & Upjohn Company LLC \| Wyeth Pharmaceutical Division of Wyeth Holdings LLC \| Pfizer Manufacturing Deutschland GmbH	2026-04-28	HUMAN PRESCRIPTION DRUG LABEL	67
Pristiq Extended-Release	PD-Rx Pharmaceuticals, Inc.	2022-07-08	HUMAN PRESCRIPTION DRUG LABEL	61
Pristiq Extended-Release	Physicians Total Care, Inc.	2012-10-26	HUMAN PRESCRIPTION DRUG LABEL	1